triple agonist glp-1 Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor ๐ A triple-action once-weekly injection
Description
It also mediates tracheal relaxation
Other GLP-1RAs (liraglutide) also elevated phosphorylation of ERK with increased transcriptional activity and the inhibitors of PD98059 and GLP-1R siRNA partially blocked the liraglutide-induced ERK signaling activation (Wu et al., 2017)
weekly vs
Benefits outlined on agelessrx.com are based on 3rd party studies
Tuttle KR, Bosch-Traberg H, Cherney DZIet al
Khan D, Sridhar A, Moffett CR
